Free radicals are toxic agents known to induce cellular oxidative damage, and reactive oxygen species plays a key role in cancer therapy. Herein, we develop an efficient delivery nanomedicine for controlled free radical generation by loading innocuous percarbamide in chitosan-coated hollow mesoporous silica nanoparticles (PCA@HMSNs-CTS). Reactive oxygen species was generated continuously and kept at a high level during the sustained release process of hydrogen peroxide from PCA@HMSNs-CTS. The evidences for mechanism revealed an autocatalytic free radical chain reactions initiated by a short time soft-X-Ray. The reactive oxygen species intensity in solutions after initiation is 5.8-fold higher than that without soft-X-Ray initiation following with the decomposition of hyperoxides and generation of oxygen. PCA@HMSNs-CTS exhibit a pH-responsive reactive oxygen species release, and the reactive oxygen species exhibit a significant high level in cancer cells which efficiently decrease the cell viability. This work explores the radical generation strategy of percarbamide nanomedicine and is expected to present a new avenue to efficient nanomedicine for cancer therapy.
CairnsRAHarrisISMakTW.Regulation of cancer cell metabolism. Nat Rev Cancer2011;
11: 85–95.
2.
ZouZChangHLiH, et al.
Induction of reactive oxygen species: An emerging approach for cancer therapy. Apoptosis2017;
22: 1321–1335.
3.
ClerkinJSNaughtonRQuineyC, et al.
Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett2008;
266: 30–36.
4.
PelicanoHCarneyDHuangP.ROS stress in cancer cells and therapeutic implications. Drug Resist Updat2004;
7: 97–110.
5.
DaiYYangZChengS, et al.
Toxic reactive oxygen species enhanced synergistic combination therapy by self-assembled metal-phenolic network nanoparticles. Adv Mater2018;
30: 1–8.
6.
FanWHuangPChenX.Overcoming the Achilles’ heel of photodynamic therapy. Chem Soc Rev2016;
45: 6488–6519.
7.
LiWPSuCHChangYC, et al.
Ultrasound-induced reactive oxygen species mediated therapy and imaging using a fenton reaction activable polymersome. ACS Nano2016;
10: 2017–2027.
8.
HuangGChenHDongY, et al.
Superparamagnetic iron oxide nanoparticles: Amplifying ROS stress to improve anticancer drug efficacy. Theranostics2013;
3: 116–126.
9.
VendittiP.Free radical involvement in doxorubicin-induced electrophysiological alterations in rat papillary muscle fibres. Cardiovasc Res1998;
38: 695–702.
10.
EfferthTOeschF.Oxidative stress response of tumor cells: Microarray-based comparison between artemisinins and anthracyclines. Biochem Pharmacol2004;
68: 3–10.
11.
HuangPElizabethA.Superoxide dismutase as a target for the selective killing of cancer cells. Nature2000;
407: 390–395.
12.
GuptaSYelLKimD, et al.
Arsenic trioxide induces apoptosis in peripheral blood T lymphocyte subsets by inducing oxidative stress: A role of bcl-2. Mol Cancer Ther2003;
2: 711–719.
13.
AgostinelliESeilerN.Non-irradiation-derived reactive oxygen species (ROS) and cancer: Therapeutic implications. Amino Acids2006;
31: 341–355.
14.
ShiJKantoffPWWoosterR, et al.
Cancer nanomedicine: Progress, challenges and opportunities. Nat Rev Cancer2017;
17: 20–37.
15.
ThirunavukkarasuGKNirmalGRLeeH, et al.
On-demand generation of heat and free radicals for dual cancer therapy using thermal initiator- and gold nanorod-embedded PLGA nanocomplexes. J Ind Eng Chem2019;
69: 405–413.
16.
PeerDKarpJMHongS, et al.
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol2007;
2: 751–760.
17.
OgawaY.Paradigm shift in radiation biology/radiation oncology-exploitation of the “H2O2 effect” for radiotherapy using low-LET (linear energy transfer) radiation such as X-rays and high-Energy electrons. Cancers2016;
8: 2–12.
18.
Martinez-OutschoornUELinZTrimmerC, et al.
Cancer cells metabolically “fertilize” the tumor microenvironment with hydrogen peroxide, driving the warburg effect: Implications for PET imaging of human tumors. Cell Cycle2011;
10: 2504–2520.
19.
IzawaSKonoKMimuraK, et al.
H2O2 production within tumor microenvironment inversely correlated with infiltration of CD56dim NK cells in gastric and esophageal cancer: Possible mechanisms of NK cell dysfunction. Cancer Immunol Immunother2011;
60: 1801–1810.
20.
ShaoYWangLFuJ, et al.
Efficient free radical generation against cancer cells by low-dose X-ray irradiation with a functional SPC delivery nanosystem. J Mater Chem B2016;
4: 5863–5872.
21.
XuLShaoYChangC, et al.
Efficient active oxygen free radical generated in tumor cell by loading-(HCONH2)·H2O2 delivery nanosystem with soft-X-ray radiotherapy. Materials2018;
11: 596.
22.
JiLLiuJQianC, et al.
Advances in the application of urea-hydrogen peroxide to oxidation reactions. Chin J Org Chem2012;
32: 254–259.
23.
LeeJELeeNKimT, et al.
Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Acc Chem Res2011;
44: 893–902.
24.
GengJLiMWuL, et al.
Mesoporous silica nanoparticle-based H2O2 responsive controlled-release system used for Alzheimer’s disease treatment. Adv Healthc Mater2012;
1: 332–336.
25.
MengHWangMLiuH, et al.
Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice. ACS Nano2015;
9: 3540–3557.
26.
XiaoDJiaHZZhangJ, et al.
A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery. Small2014;
10: 591–598.
27.
TarnDAshleyCEXueM, et al.
Mesoporous silica nanoparticle nanocarriers: Biofunctionality and biocompatibility. Acc Chem Res2013;
46: 792–801.
28.
HeQShiJ.Mesoporous silica nanoparticle based nano drug delivery systems: Synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem2011;
21: 5845–5855.
29.
HeQGaoYShiJ, et al.
A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. Biomaterials2011;
32: 7711–7720.
30.
LiuJBuWPanL, et al.
NIR-triggered anticancer drug delivery by upconverting nanoparticles with integrated azobenzene-modified mesoporous silica. Angew Chem Int Ed2013;
52: 4375–4379.
31.
HeQGaoYBuW, et al.
One-pot self-assembly of mesoporous silica nanoparticle-based pH-responsive anti-cancer nano drug delivery system. J Mater Chem2011;
21: 15190–15192.
32.
BarillaJLokajicekM.The role of oxygen in DNA damage by ionizing particles. J Theor Biol2000;
207: 405–414.
33.
ZhaoYZhuY.Synergistic cytotoxicity of low-energy ultrasound and innovative mesoporous silica-based sensitive nanoagents. J Mater Sci2014;
49: 3665–3673.
34.
FangXChenCLiuZ, et al.
A cationic surfactant assisted selective etching strategy to hollow mesoporous silica spheres. Nanoscale2011;
3: 1632–1639.
35.
ChenYYinQShiJ, et al.
Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. Biomaterials2012;
33: 7126–7137.
36.
FuJShaoYShiC, et al.
Selective intracellular free radical generation against cancer cells by bioactivation of low-dose artesunate with a functionalized mesoporous silica nanosystem. J Mater Chem B2014;
2: 6984–6994.
37.
FuJZhuYZhaoY.Controlled free radical generation against tumor cells by pH-responsive mesoporous silica nanocomposite. J Mater Chem B2014;
2: 3538–3548.
38.
Fu J, Shao Y, Wang L, et al. Lysosome-controlled efficient ROS overproduction against cancer cells with a high pH-responsive catalytic nanosystem Nanoscale 2015; 7: 7275–7283.
39.
ChenFZhuY.Chitosan enclosed mesoporous silica nanoparticles as drug nano-carriers: Sensitive response to the narrow pH range. Microporous Mesoporous Mater2012;
150: 83–89.
40.
RitgerPLPeppasNA.A simple equation for description of soulte release I. fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release1987;
5: 23–36.
41.
RitgerPLPeppasNA.A simple equation for description of soulte release II. fickian and anomalous release from swellable devices. J Control Release1987;
5: 37–42.
42.
BuxtonGVGreenstockCLHelmanWP, et al.
Critical review of rate constants for reactions of hydrated electrons, hydrogen atoms and hydroxyl radicals (⋅OH/⋅O− in aqueous solution. J Phy Chem Ref Data2009;
17: 513–886.
43.
DalyMJ.A new perspective on radiation resistance based on deinococcus radiodurans. Nat Rev Microbiol2009;
7: 237–245.
44.
IllésETegzeAKovácsK, et al.
Hydrogen peroxide formation during radiolysis of aerated aqueous solutions of organic molecules. Radiat Phys Chem2017;
134: 8–13.
45.
BurnsWGSimsHE.Effect of radiation type in water radiolysis. J Chem Soc, Faraday Trans 11981;
77: 2803–2813.
46.
ZastrowLGrothNKleinF, et al.
The missing link-light-induced (280-1,600 nm) free radical formation in human skin. Skin Pharmacol Physiol2009;
22: 31–44.
47.
FuJShaoYWangL, et al.
Lysosome-controlled efficient ROS overproduction against cancer cells with a high pH-responsive catalytic nanosystem. Nanoscale2015;
7: 7275–7283.
48.
DickinsonBCChangCJ.Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol2011;
7: 504–511.
49.
BeggACStewartFAVensC.Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer2011;
11: 239–253.
50.
CuiQWangJQAssarafYG, et al.
Modulating ROS to overcome multidrug resistance in cancer. Drug Resist Updat2018;
41: 1–25.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
